|
August 30, 2006
September 5, 2006 Forbes Medi-Tech Announces Second Quarter 2006 ResultsAugust 15, 2006 Forbes Medi-Tech Announces Progress in Pharmaceutical Development and Expansion of Reducol-Based Products at UK's Largest Retailer, Tesco Stores LtdAugust 8, 2006 iCo Therapeutics Appoints Chief Medical OfficerAugust 17, 2006 Inex Pharmaceuticals: Commencement of INX-0125 Phase 1 Clinical TrialAugust 30, 2006 INEX Seeks Approval to Spin-Out Assets Into Tekmira PharmaceuticalsAugust 24, 2006 INEX Releases Second Quarter 2006 Operating ResultsAugust 3, 2006 Inflazyme Pharmaceuticals Ltd.: Financial Results for the Quarter Ended June 30, 2006August 14, 2006 Med Biogene Inc. reports financial results for second quarter 2006August 30, 2006 Med BioGene reports promising pre-clinical results of its Diagnostic Lymphoma DNA Bioarray; biomarkers effective in diagnosing major lymphoma subtypesAugust 3, 2006 MIGENIX to Present Celgosivir Synergy Data at the 13th International Meeting of Hepatitis C Virus & Related VirusesAugust 29, 2006 Nventa signs supply agreement for proprietary adjuvant for use with HspE7August 23, 2006 Nventa Biopharmaceuticals Corporation announces second quarter 2006 financial resultsAugust 9, 2006 Nventa to receive $2.8 million from escrow accountAugust 4, 2006 Ondine Biopharma Hires Sales and Marketing Executive for Global Expansion of Periowave(TM)August 28, 2006 Ondine Biopharma Announces 2006 Second Quarter Financial ResultsAugust 14, 2006
August 30, 2006
Perceptronix Receives Health Canada License for Early Lung Cancer Test August 21, 2006 Protox announces new Director of Investor Relations and Corporate CommunicationsAugust 24, 2006 Protox advances Phase I prostate cancer study and planned BPH clinical trialAugust 10, 2006 QLT Announces Commencement of Tender OfferAugust 3, 2006 Tissue Therapies, Ltd., signs 2nd cGMP manufacturing contract with QSV Biologics, Ltd., for Synthetic Vitronectin and Chimeric VitroGro(R)-1August 23, 2006 cGMP Manufacturing Contract Signed by Proteon Therapeutics, Inc., and QSV Biologics, Ltd., for PRT-201 Clinical Phase I Material SupplyAugust 10, 2006 Welichem announces grant of incentive stock optionsSeptember 1, 2006 WEX Pharmaceuticals: Meeting with BGTD of Health CanadaAugust 25, 2006
|
